Home > Boards > US Listed > Biotechs > Synthetic Biologics, Inc. (SYN)

$SYN was over $100.00 per share a few

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SpotOnTrade Member Profile
Member Level 
Followed By 702
Posts 108,952
Boards Moderated 7
Alias Born 08/13/10
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2019 4:38:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2019 4:21:33 PM
Synthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial Results PR Newswire (US) - 11/4/2019 4:10:00 PM
Synthetic Biologics to Report 2019 Third Quarter Operational Highlights and Financial Results on November 4, 2019 PR Newswire (US) - 10/28/2019 4:30:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 9/26/2019 5:05:45 PM
Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome... PR Newswire (US) - 9/26/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/6/2019 6:03:48 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 5:01:01 PM
Synthetic Biologics to Report 2019 Second Quarter Operational Highlights and Financial Results on August 8, 2019 PR Newswire (US) - 8/1/2019 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 7/15/2019 5:16:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2019 7:06:03 AM
Synthetic Biologics Regains Compliance with NYSE American Continued Listing Standards PR Newswire (US) - 7/1/2019 7:00:00 AM
Sýn hf. : First quarter results in a profit of ISK 670 million GlobeNewswire - 5/15/2019 12:26:39 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 5:06:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:17:37 PM
Synthetic Biologics Reports First Quarter 2019 Operational Highlights and Financial Results PR Newswire (US) - 5/8/2019 4:10:00 PM
Synthetic Biologics to Report 2019 First Quarter Operational Highlights and Financial Results on May 8, 2019 PR Newswire (US) - 4/30/2019 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2019 5:15:49 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/3/2019 5:15:25 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/1/2019 5:02:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/4/2019 5:03:56 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/27/2019 5:05:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/27/2019 4:19:26 PM
Synthetic Biologics Reports 2018 Year End Operational Highlights and Financial Results PR Newswire (US) - 2/27/2019 4:10:00 PM
Sýn hf. : Q4 Investors presentation GlobeNewswire - 2/27/2019 3:03:57 PM
SpotOnTrade Member Level  Thursday, 03/21/19 07:30:45 PM
Re: Wildbilly post# 8066
Post # of 8128 
$SYN was over $100.00 per share a few years back. Synthetic Biologics, Inc. Elliott wave is in full effect.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist